Bloomberg News is looking for an ambitious news breaker to cover the biggest US drug companies: Pfizer, J&J, Bristol-Myers and Merck, which are all in various stages of trying to reinvent themselves as some of their blockbuster drugs face generic competition later this decade.
You are an experienced and versatile reporter who can break news on dynamic and evolving corporate stories, analyze and translate scientific research and breakthroughs, and keep tabs on the enormous power the pharma industry wields as the largest industry lobby in Washington. You are motivated by scoops and the ability to conceive and execute ambitious enterprise and investigative projects that map out the future of big pharma.
To apply, go here.
Dow Jones & Co., the parent of The Wall Street Journal, Barron's, MarketWatch.com and Investor's…
The Wall Street Journal is seeking a White House reporter in Washington, DC, to break…
Ben Pershing, the politics editor of The Wall Street Journal, is leaving the news organization.…
New York Times executive editor Joe Kahn sent out the following on Friday: A January 2010 front…
Brent Jones, the senior vice president of training, culture and community at Dow Jones, is…
The Wall Street Journal is looking for an editor to lead its coverage of logistics…